Delayed low-dose supplemental oxygen improves survival following phosgene-induced acute lung injury

Inhalation Toxicology

Volumn 22, Issue 7, 2010, Pages 552-560

  Grainge, C ^a   Jugg, B J ^b   Smith, A J ^b   Brown, R F R ^b   Jenner, J ^b   Parkhouse, D A ^c   Rice, P ^b  

^a INSTITUTE OF NAVAL MEDICINE   (United Kingdom)

^b Biomedical Sciences   (United Kingdom)

^c BROOMFIELD HOSPITAL   (United Kingdom)

Author keywords

Administration; Animals; Chemical warefare agents; Inhalation; Oxygen; Phosgene; Pulmonary edema; Treatment

Indexed keywords

PHOSGENE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD OXYGEN TENSION; CONTROLLED STUDY; FEMALE; HYPOXIA; INTERMITTENT POSITIVE PRESSURE VENTILATION; LEUKOCYTE COUNT; LUNG WEIGHT; NONHUMAN; OXYGEN CONCENTRATION; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SURVIVAL RATE; SWINE; TIDAL VOLUME;

ACUTE LUNG INJURY; ADMINISTRATION, INHALATION; ANIMALS; FEMALE; OXYGEN; OXYGEN INHALATION THERAPY; PHOSGENE; SURVIVAL RATE; SUS SCROFA; TIME FACTORS;

ANIMALIA; SUIDAE;

EID: 77952828361     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958370903571831     Document Type: Article

References (28)

1. Altman DG, Machin D, Bryant TN, Gardner MJ eds, . 2000. Statistics with Confidence. 2nd ed. London: BMJ Books.
2. Bateman NT, Leach RM. 1998. ABC of oxygen: Acute oxygen therapy. BMJ 317:798-801.
3. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. 1994. The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination Am J Respir Crit Care Med 149: 818-824. (Pubitemid 24082248)
4. Borak J, Diller WF. 2001. Phosgene exposure: Mechanisms of injury and treatment strategies. J Occup Environ Med 43:110-119.
5. Borg T, Alvfors A, Gerdin B, Modig J. 1985. A porcine model of early adult respiratory distress syndrome induced by endotoxaemia. Acta Anaesth Scand 29:814-830.
6. Brown RFR, Jugg BJA, Harban FMJ, Ashley Z, Kenward CE, Platt J, Hill A, Rice P, Watkins PE. 2002. Pathophysiological responses following phosgene exposure in the anaesthetized pig. J Appl Toxicol 22:263-269.
7. Chabot F, Mitchell JA, Gutteridge JM, Evans TW 1998. Reactive oxygen species in acute lung injury. Eur Respir J 11:745-757.
8. Dehring DJ, Crocker SH, Wismar BL, Steinberg SM, Lowery BD, Cloutier CT. 1983. Comparison of live bacteria infusions in a porcine model of acute respiratory failure. J Surg Res 34:151-158.
9. Diller WF. 1985. Pathogenesis of phosgene poisoning. Toxicol Ind Health 1: 7-15.
10. Diller WF, Zante RA. 1985. Literature review: Therapy for phosgene poisoning. Toxicol Ind Health 1:117-128.
11. Edwards JD, Shoemaker WC, Vincent J-L. 1993. Oxygen Transport: Principles and Practice. London: Saunders, Appendix II.
12. Fisher AB, Beers MF. 2008. Hyperoxia and acute lung injury. Am J Physiol Lung Cell Mol Physiol 295:L1066.
13. Grainge C. 2004. Breath of life: The evolution of oxygen therapy. JRSM 97:489-493.
14. Karmrodt J, Bletz C, Yuan S, David S, Heussel C-P, Markstaller K. 2006. Quantification of atelectatic lung volumes in two different porcine models of ARDS. Br J Anaesth 97:883-895.
15. Knight PR, Kurek C, Davidson BA, Nader ND, Patel A, Sokolowski J, Notter RH, Holm BA. 2000. Acid aspiration increases sensitivity to increased ambient oxygen concentrations. Am J Physiol Lung Cell Mol Physiol 278:L1240-L1247.
16. Manning AM. 2002. Oxygen therapy and toxicity. Vet Clin Small Anim 32:1005-1020.
17. Matthay MA, Zimmerman GA, Esmon C, Bhattachaeya J, Coller BM, Doerschuk C, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, Leppert M, Matalon S, Munford R, Parsons P, Slutsky AS, Tracey KJ, Ward P, Gail DB, Harabin AL. 2003. Future research directions in acute lung injury. Am J Respir Crit Care Med 167:1027-1035.
18. Maynard RL. 1996. Phosgene. In: Marrs TC, Maynard RJ, Sidell FR, editors. Chemical Warfare Agents: Toxicology and Treatment. Chichester: John Wiley, 477-494.
19. Murray LA, Knight DA, McAlonan L, Argentieri R, Joshi A, Shaheen F, Cunningham M, Alexopolou L, Flavell RA, Sarisky RT, Hogaboam CM. 2008. Deleterious role of TLR3 during hyperoxia-induced acute lung injury. Am J Resp Crit Care 178:1227-1237.
20. Nirmalan M, Willard T, Columb M O, Nightingale P. 2001. Effects of changes in arterial-mixed venous oxygen content difference (C(a-v)O2) on indices of pulmonary oxygen transfer in a model of ARDS lung. Br J Anaesth 86:477-485.
21. Parker SJ, Hill PF, Brown D, Kenward CE, Watkins PE. 2000. A porcine model of sepsis resulting from combined insults of hemorrhage and peritonitis. Shock 13:291-296.
22. Parkhouse DA, Brown RF, Jugg BA, Harban FM, Platt J, Kenward CE, John J, Rice P, Smith AJ. 2007. Protective ventilation strategies in the treatment of phosgene induced lung injury. Military Med 172:295-300.
23. Sciuto AM, Stotts RR, Hurt HH. 1996. Efficacy of ibuprofen and pentoxifylline in the treatment of phosgene-induced acute lung injury. J Appl Toxicol 16:381-384.
24. Sciuto AM, Hurt HH. 2004. Therapeutic treatments of phosgene-induced lung injury. Inhal Toxicol 16:565-580.
25. Wang J, Zhang L, Walther SM. 2002. Inhaled budesonide in experimental chlorine gas lung injury: Influence of time interval between injury and treatment. Intensive Care Med 28:352-357.
26. Ware LB, Matthay MA. 2000. The acute respiratory distress syndrome. N Engl J Med 342:1334-1349.
27. Woodall J. 1997. Tokyo subway gas attack. Lancet 350:296.
28. Wyatt JP, Allister CA. 1995. Occupational phosgene poisoning-A case report and review. J Accid Emerg Med 12:212-213.